Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Teva's Nuvigil Patent Infringement Lawsuits Resolved
Yahoo/Zacks.com
Thursday, June 19, 2014 - 5:47pm
tags:
NUVIGIL, patents, Teva Pharmaceuticals, Sandoz, Apotex, Mylan Labs, Actavis, Lupin
Isis Could Get a $2 Billion Gain From Heart Attack Trials
Bloomberg
Thursday, June 19, 2014 - 5:44pm
tags:
heart attack, Isis Pharmaceuticals, ISIS-APOCIIIRx
Is Pfizer Putting the Car-T Before the Horse?
Motley Fool
Thursday, June 19, 2014 - 5:43pm
tags:
Pfizer, CAR-T, Cellectis
Cubist Readies For Takeoff With New Antibiotic Launch
Investors.com
Thursday, June 19, 2014 - 5:39pm
tags:
antibiotics, Cubist Pharmaceuticals, Sivextro
The Case For and Against Valeant Pharmaceuticals
Motley Fool
Thursday, June 19, 2014 - 11:38am
tags:
Valeant Pharmaceuticals, M&A, Allergan
15 Highest-Paid Biopharma CEOs of 2013
Fierce Pharma
Thursday, June 19, 2014 - 11:36am
tags:
executive pay
FDA takes on Twitter and other online etiquette for medtech makers
Mass Device
Thursday, June 19, 2014 - 11:08am
tags:
FDA, social media, devices
Dr. Reddy’s to Invest in Biologics, Proprietary Medicines
Bloomberg
Thursday, June 19, 2014 - 11:07am
tags:
Dr Reddy's, India
Study: Suicides rise in wake of 'black box' warnings on antidepressants
Fierce Pharma
Thursday, June 19, 2014 - 10:55am
tags:
antidepressants, suicide, black box
NICE backs thousands more scripts for clot-fighters Pradaxa, Xarelto, and Eliquis
Fierce Pharma
Thursday, June 19, 2014 - 10:36am
tags:
NICE, Pradaxa, Xarelto, bloodthinners, Eliquis, Bayer, JNJ, Pfizer, Bristol-Myers Squibb, Boehringer Ingelheim
StemCells early AMD data a 'best case' outcome, says Maxim
The Fly on the Wall
Thursday, June 19, 2014 - 10:19am
tags:
StemCells, dry age-related macular degeneration
Is This MannKind's Biggest Risk?
Motley Fool
Thursday, June 19, 2014 - 9:22am
tags:
MannKind, diabetes, Afrezza
Prestigious Cancer Hospital Rebukes Northwest Bio for 'Inappropriate' Data Disclosures
TheStreet.com
Thursday, June 19, 2014 - 8:55am
tags:
Northwest Biotherapeutics, MD Anderson Cancer Center, DCVax Direct
Sovaldi And Drug Pricing: The United States Of Saps (GILD)
Seeking Alpha
Thursday, June 19, 2014 - 8:54am
tags:
Sovaldi, drug pricing, hepatitis C, Gilead Sciences
IPO Preview: Ardelyx (ARDX)
Seeking Alpha
Thursday, June 19, 2014 - 8:53am
tags:
IPOs, Ardelyx, Sanofi, AstraZeneca
Drug-maker Valeant begins exchange offer for Allergan
Yahoo/Reuters
Thursday, June 19, 2014 - 8:51am
tags:
Valeant Pharmaceuticals, Allergan, hostile bid, M&A
Medtronic vs. Johnson & Johnson: Meet the Market's Biggest New Rivalry
Motley Fool
Wednesday, June 18, 2014 - 5:46pm
tags:
Medtronic, JNJ, devices
OncoMed: FDA places partial clinical hold on Phase 1 trials of FZD8-Fc
The Fly on the Wall
Wednesday, June 18, 2014 - 5:41pm
tags:
OncoMed, FDA, FZD8-Fc
Pfizer XELJANZ Phase 3 findings support safety, efficacy
Yahoo/Fly on the Wall
Wednesday, June 18, 2014 - 5:39pm
tags:
Pfizer, Xeljanz, rheumatoid arthritis
Big biotech booms while pharma payrolls wither
Fierce Biotech
Wednesday, June 18, 2014 - 4:27pm
tags:
biotech, Big Pharma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.